Why Researchers Are Concerned

A growing body of research suggests that payment incentives in healthcare often shape clinical behavior, sometimes at the expense of patient care. A 2023 study published in JAMA Health Forum found that hospitals increased use of certain medical devices by up to 30% after Medicare expanded reimbursem

What Hospitals and Tech Companies Are Doing

Hospitals are already integrating AI tools into routine care, particularly in radiology, cardiology, and emergency medicine. For example, AI powered stroke detection algorithms are now used in nearly 40% of U.S. stroke centers, up from just 10% in 2020. Tech companies, meanwhile, are racing to secur

What’s Next for AI in Healthcare

The Centers for Medicare & Medicaid Services (CMS) has not yet signaled plans to adjust its payment policies, but pressure is growing from researchers and watchdog groups. In the meantime, hospitals and clinicians are left to navigate the trade offs between innovation and cost. For patients, the

Medicare AI Device Payments May Drive Overuse, Researchers Warn

Medicare has begun reimbursing hospitals for the use of newly authorized AI based medical devices, but researchers warn this could create financial incentives for overuse. While AI tools promise to improve diagnostics and treatment, experts caution that payment structures may prioritize volume over clinical necessity, potentially driving up healthcare costs and exposing patients to unnecessary procedures. The shift reflects broader tensions between innovation and cost control in the U.S. healthcare system.

Medicare has introduced new payment policies for AI driven medical devices, reimbursing hospitals each time these tools are used in patient care. The move aims to accelerate adoption of AI technologies that can enhance diagnostics, streamline workflows, and improve clinical decision making. However, the per use payment model has raised concerns among health policy researchers, who argue it may encourage hospitals to deploy AI tools more frequently than medically necessary.

Under the current system, hospitals receive additional payments when they use FDA authorized AI devices, such as those for detecting strokes, analyzing imaging scans, or predicting patient deterioration. While these tools have demonstrated potential to reduce errors and improve outcomes, critics say the financial incentives could lead to overutilization, particularly in fee for service settings where volume drives revenue.